Share
27,042 Posts.
lightbulb Created with Sketch. 1748
clock Created with Sketch. 14/05/24
15:49
Share
Originally posted by fourdollars
↑
Can only speak for myself, but given the SP, maybe my view is not unique ...
Expand
You were expecting commercialisation when HER-Vaxx wasn't even close to Ph1 clinical trial completion??? Come-on bruh, you are not clueless investor of biotech start-up stock. I think there's still a big market for HER-Vaxx as not all treatment current or future will work and Chemotherapy is the last treatment so if HER-Vaxx (still need more clinical data) can assist patient to increase the efficacy of Chemotherapy treatment with adding no toxicity then why wouldn't there be a market for this?????
(20min delay)